Magnetic resonance imaging of prostate cancer: Diffusion-weighted imaging in comparison with sextant biopsy

Journal of Computer Assisted Tomography

Volumn 35, Issue 2, 2011, Pages 223-228

  Yamamura, Jin ^a   Salomon, Georg ^a   Buchert, Ralph ^a   Hohenstein, Arne ^a   Graessner, Joachim ^b   Huland, Hartwig ^a   Graefen, Markus ^a   Adam, Gerhard ^a   Wedegaertner, Ulrike ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b SIEMENS AG   (Germany)

Author keywords

DWI; MRI; prostate

Indexed keywords

BIOPSY; CORRELATION METHODS; DISEASES; MAGNETISM; RESONANCE; SEXTANTS; SURFACE DIFFUSION; TUMORS; UROLOGY;

APPARENT DIFFUSION COEFFICIENT; COEFFICIENT VALUES; DIFFUSION WEIGHTED IMAGING; DISCRIMINATION THRESHOLDS; GLEASON SCORES; PEARSON CORRELATION; PROSTATE; PROSTATE CANCERS; STUDY GROUPS; TUMOUR TISSUE;

MAGNETIC RESONANCE IMAGING;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER TISSUE; CORRELATION COEFFICIENT; DIAGNOSTIC TEST ACCURACY STUDY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NONPARAMETRIC TEST; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SEXTANT BIOPSY; TRANSRECTAL ULTRASONOGRAPHY;

EID: 79953811418     PISSN: 03638715     EISSN: None     Source Type: Journal    
DOI: 10.1097/RCT.0b013e3181fc5409     Document Type: Article

References (31)

1. Hayat MJ, Howlader N, Reichman ME, et al. Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. Oncologist. 2007;12:20-37. (Pubitemid 46143500)
2. Levi F, Lucchini F, Negri E, et al. Leveling of prostate cancer mortality in western Europe. Prostate. 2004;60:46-52. (Pubitemid 38669228)
3. Purohit RS, Shinohara K, Meng MV, et al. Imaging clinically localized prostate cancer. Urol Clin North Am. 2003;30:279-293. (Pubitemid 36520600)
4. Ikonen S, Kivisaari L, Tervahartiala P, et al. Prostatic MR imaging. Accuracy in differentiating cancer from other prostatic disorders. Acta Radiol. 2001;42:348-354.
5. Sanchez-Chapado M, Angulo JC, Ibarburen C, et al. Comparison of digital rectal examination, transrectal ultrasonography, and multicoil magnetic resonance imaging for preoperative evaluation of prostate cancer. Eur Urol. 1997;32:140-149. (Pubitemid 27386951)
6. Franiel T, Fritzsche F, Staack A, et al. [Histopathologic quality of prostate core biopsy specimens: comparison of an MR-compatible biopsy needle and a ferromagnetic biopsy needle used for ultrasound-guided prostate biopsy]. Rofo. 2006;178:1212-1218.
7. Kurhanewicz J, Vigneron DB, Hricak H, et al. Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution. Radiology. 1996;198:795-805. (Pubitemid 26066301)
8. Le Moyec L, Pellen P, Merdrignac-Le Noan G, et al. Proton NMR relaxation times of experimental Lewis lung carcinoma after irradiation. Radiother Oncol. 1988;13:1-8.
9. Taouli B, Vilgrain V, Dumont E, et al. Evaluation of liver diffusion isotropy and characterization of focal hepatic lesions with two single-shot echo-planar MR imaging sequences: prospective study in 66 patients. Radiology. 2003;226:71-78. (Pubitemid 36163910)
10. Sumi M, Takagi Y, Uetani M, et al. Diffusion-weighted echoplanar MR imaging of the salivary glands. AJR Am J Roentgenol. 2002;178:959-965. (Pubitemid 34250239)
11. Matoba M, Tonami H, Kondou T, et al. Lung carcinoma: diffusion-weighted MR imaging - preliminary evaluation with apparent diffusion coefficient. Radiology. 2007;243:570-577. (Pubitemid 46649714)
12. Shimofusa R, Fujimoto H, Akamata H, et al. Diffusion-weighted imaging of prostate cancer. J Comput Assist Tomogr. 2005;29:149-153. (Pubitemid 40411296)
13. Hosseinzadeh K, Schwarz SD. Endorectal diffusion-weighted imaging in prostate cancer to differentiate malignant and benign peripheral zone tissue. J Magn Reson Imaging. 2004;20:654-661. (Pubitemid 39313742)
14. Issa B. In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo-planar imaging. J Magn Reson Imaging. 2002;16:196-200.
15. Riches SF, Payne GS, Morgan VA, et al. MRI in the detection of prostate cancer: combined apparent diffusion coefficient, metabolite ratio, and vascular parameters. AJR Am J Roentgenol. 2009;193: 1583-1591.
16. Kumar V, Jagannathan NR, Kumar R, et al. Apparent diffusion coefficient of the prostate in men prior to biopsy: determination of a cut-off value to predict malignancy of the peripheral zone. NMR Biomed. 2007;20:505-511. (Pubitemid 47272370)
17. Mazaheri Y, Shukla-Dave A, Hricak H, et al. Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging - correlation with pathologic findings. Radiology. 2008;246:480-488.
18. Le Bihan D, Poupon C, Amadon A, et al. Artifacts and pitfalls in diffusion MRI. J Magn Reson Imaging. 2006;24:478-488. (Pubitemid 44320549)
19. Boni RA, Hutter BE, Trinkler F, et al. [Preoperative T-staging of prostatic carcinoma: endorectal magnetic resonance tomography compared with other imaging and clinical methods]. Rofo. 1996;165:152-158.
20. Wetter A, Ajdukovic AN, Fliessbach K, et al. [Staging of prostate cancer: value of the combined information of endorectal MRI, biopsy Gleason score, and preoperative PSA level]. Rofo. 2006;178:385-390.
21. Engelbrecht MR, Jager GJ, Laheij RJ, et al. Local staging of prostate cancer using magnetic resonance imaging: a meta-analysis. Eur Radiol. 2002;12:2294-2302. (Pubitemid 36940327)
22. Yu KK, Hricak H. Imaging prostate cancer. Radiol Clin North Am. 2000;38:59-85, viii.
23. Hricak H, White S, Vigneron D, et al. Carcinoma of the prostate gland: MR imaging with pelvic phased-array coils versus integrated endorectal-pelvic phased-array coils. Radiology. 1994;193:703-709. (Pubitemid 24366938)
24. Quint LE, Van Erp JS, Bland PH, et al. Prostate cancer: correlation of MR images with tissue optical density at pathologic examination. Radiology. 1991;179:837-842.
25. Ikonen S, Karkkainen P, Kivisaari L, et al. Endorectal magnetic resonance imaging of prostatic cancer: comparison between fat-suppressed T2-weighted fast spin echo and three-dimensional dual-echo, steady-state sequences. Eur Radiol. 2001;11:236-241. (Pubitemid 32755442)
26. Jager GJ, Ruijter ET, van de Kaa CA, et al. Dynamic TurboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic results. Radiology. 1997; 203:645-652. (Pubitemid 27227409)
27. Morgan VA, Kyriazi S, Ashley SE, et al. Evaluation of the potential of diffusion-weighted imaging in prostate cancer detection. Acta Radiol. 2007;48:695-703. (Pubitemid 47147765)
28. Sato C, Naganawa S, Nakamura T, et al. Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate. J Magn Reson Imaging. 2005;21:258-262. (Pubitemid 40280120)
29. Miao H, Fukatsu H, Ishigaki T. Prostate cancer detection with 3-T MRI: comparison of diffusion-weighted and T2-weighted imaging. Eur J Radiol. 2007;61:297-302. (Pubitemid 46096691)
30. Tanimoto A, Nakashima J, Kohno H, et al. Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging. J Magn Reson Imaging. 2007;25:146-152. (Pubitemid 46095209)
31. Tamada T, Sone T, Jo Y, et al. Apparent diffusion coefficient values in peripheral and transition zones of the prostate: comparison between normal and malignant prostatic tissues and correlation with histologic grade. J Magn Reson Imaging. 2008;28:720-726.